Skip to main content
. 2022 Jan 10;12:781425. doi: 10.3389/fphar.2021.781425

TABLE 5.

EGFR antibody for active targeting of nanoparticle drug delivery systems.

Types PDI Zeta potential (mV) Size (nm)
ECMI Zhang et al. (2019) 0.41 ± 0.03 −18.5 ± 1.7 220.0 ± 3.5
Dox-EGF-PEAL NPs 0.182 3.5 ± 0.88 203.7 ± 7.42
Bcl-2-EGF-PEAL NPs Zhang et al. (2016) 0.217 2.1 ± 1.24 206.5 ± 6.37
AP/ES Lv et al. (2018) 0.27 ± 0.01 12.1 ± 0.1 383.1 ± 0.4